Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNiox Group Regulatory News (NIOX)

Share Price Information for Niox Group (NIOX)

Share Price is delayed by 15 minutes
Get Live Data
59.40    -0.20 (-0.34%)
Bid:
58.00
Ask:
59.00
Spread: 1.00 (1.724%)
Market Cap: £249.99m
NIOX Live PriceLast checked at - London Stock Exchange

Intraday Niox Group Share Chart

Director/PDMR Shareholding

1 Apr 2025 08:00

RNS Number : 0209D
Niox Group PLC
01 April 2025
 

NIOX Group plc

("NIOX" or the "Company")

 

Director/PDMR Shareholding

 

Oxford, UK - 1 April 2025: NIOX Group plc (AIM: NIOX) announces it has today issued 363,006 new ordinary shares in the Company ("Ordinary Shares") to its Executive Directors under the Company's Deferred Share Bonus Plan (the "Plan").

 

The share issue was made in respect of the annual bonus for the 2022 financial year, which was granted on 28 March 2023. Under the terms of the company's remuneration policy, 75% of this bonus was deferred for two years, other than for the sale of shares to satisfy any tax liability created on grant. The allotment of shares took place today following the release of the Company's year-end results earlier this morning, which marks the end of the Company's closed period.

 

The 363,006 new Ordinary Shares issued in connection with these awards are subject to an existing block admission for the respective Plan and rank pari passu with the Company's existing Ordinary Shares.

 

The number of Ordinary Shares that were today allotted to each Executive Director and their resultant interest in the Company is as follows:

 

Number of Ordinary Shares issued

Resulting number of Ordinary Shares held

Resulting interest in the Company

Ian Johnson

136,558

1,071,069

0.26%

Jonathan Emms

127,454

1,069,123

0.26%

Michael Roller

98,994

800,852

0.20%

 

Voting rights

Following the above, the Company's issued share capital comprises 408,343,556 Ordinary Shares, 398,343,556 Ordinary Shares with equal voting rights, and 10,000,000 shares held in Treasury. This figure of 398,343,556 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure, Guidance and Transparency Rules.

 

Additional details are provided below in accordance with the requirements of UK MAR.

 

For further information, please contact:

 

NIOX Group plc

Ian Johnson, Executive Chairman

Michael Roller, Chief Financial Officer

Sarah Duncan, Company Secretary

 

 

+44 (0) 3303 309 356

 

 

Singer Capital Markets (Nominated Adviser and Joint Broker)

Jen Boorer / James Fischer / James Todd

 

+44 (0) 20 7496 3000

Investec Bank plc (Financial Adviser and Joint Broker)

Ben Lawrence / Lydia Zychowska

+44 (0) 20 7597 4000

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Ian Johnson

2. Jonathan Emms

3. Michael Roller

2.

Reason for the notification

a.

Position/status

1. Executive Chairman

2. Chief Executive Officer

3. Chief Financial Officer

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

NIOX Group plc

b.

LEI

2138006YAT138TOGA556

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary Shares of 0.08p each

 

 

GB00BJVD3B28

b.

Nature of the transaction

 

Issue of new Ordinary Shares under the Deferred Share Bonus Plan

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1. 0.08p

2. 0.08p

3. 0.08p

 

1. 136,558

2. 127,454

3. 98,994

d.

Aggregated information

· Aggregated volume

· Price

 

 

n/a

 

e.

Date of the transaction

01/04/2025

f.

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHJBMPTMTJJBBA
Date   Source Headline
22nd May 202412:07 pmRNSResult of Annual General Meeting
22nd May 20247:00 amRNSAGM Statement
1st May 20247:00 amRNSTotal Voting Rights Update
29th Apr 20245:00 pmRNSGrant of SAYE options
22nd Apr 20244:37 pmRNSNotice of 2024 Annual General Meeting
5th Apr 20243:10 pmRNSDirector/PDMR Shareholding
4th Apr 20242:10 pmRNSDividend Timetable
3rd Apr 20241:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20249:00 amRNSReplacement: Block listing Interim Review
2nd Apr 20245:50 pmRNSBlock listing Interim Review
2nd Apr 20241:45 pmRNSReplacement: Director/PDMR Shareholding
28th Mar 20244:45 pmRNSDirector/PDMR Shareholding
28th Mar 20243:00 pmRNSGrant of options
27th Mar 20242:00 pmRNSExercise of SAYE Options
26th Mar 20247:00 amRNSFinal Results
22nd Mar 20244:00 pmRNSBlock Admission
1st Feb 20247:00 amRNSTotal Voting Rights Update
18th Jan 20247:00 amRNSAppointment of Financial Adviser and Joint Broker
18th Jan 20247:00 amRNSFull Year Trading Update
2nd Jan 20248:30 amRNSTotal Voting Rights Update
19th Dec 20233:46 pmRNSHolding(s) in Company
1st Dec 20239:20 amRNSTotal Voting Rights Update
6th Nov 202311:44 amRNSBlock Listing Applicationn
2nd Nov 20239:00 amRNSTotal Voting Rights Update
30th Oct 202310:52 amRNSHolding(s) in Company
16th Oct 20239:58 amRNSHolding(s) in Company
11th Oct 202310:09 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSBlock Listing Interim Review
27th Sep 202310:30 amRNSHolding(s) in Company
26th Sep 20237:00 amRNSInterim Results - Ended 30 June 2023
31st Aug 20239:40 amRNSTotal Voting Rights Update
28th Jul 20231:07 pmRNSBlock Admission
18th Jul 20237:00 amRNSTrading Update
7th Jun 20237:00 amRNSReturn of Capital by way of special Dividend
19th May 202310:51 amRNSHolding(s) in Company
18th May 20233:47 pmRNSResult of AGM
18th May 20237:00 amRNSAGM Statement
19th Apr 20236:00 pmRNSNotice of AGM
31st Mar 202310:52 amRNSBlock listing Interim Review
29th Mar 20238:03 amRNSDirector/PDMR Shareholding
28th Mar 20234:04 pmRNSGrant of options
27th Mar 202312:15 pmRNSAnnual Report
24th Mar 20231:00 pmRNSBlock Admission
21st Mar 20237:00 amRNSPreliminary Results
10th Feb 20237:58 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSTrading Statement
8th Nov 20224:45 pmRNSConfirmation of Capital Reduction
6th Oct 202210:45 amRNSResult of GM and Proposed Capital Reduction
30th Sep 202212:15 pmRNSReplacement: Block listing Cancellation and Review
30th Sep 20229:31 amRNSBlock Listing Cancellation and Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.